A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects

Clinical trial NCT01793649 · TERMINATED

Trial details

NCT number: NCT01793649
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis Chronic Obstructive Pulmonary Disease

Start date: 2012-10-01
Primary completion: 2013-06-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.